Status:
UNKNOWN
A Randomized Controlled Trial of Individual Therapy for First Episode Psychosis
Lead Sponsor:
Ontario Mental Health Foundation
Collaborating Sponsors:
Schizophrenia Society of Ontario
Conditions:
Psychosis
Eligibility:
All Genders
16-35 years
Phase:
EARLY_PHASE1
Brief Summary
In the first year of treatment after a FE of SCZ, 75% to 90% of patients achieve remission from psychotic symptoms. However, approximately 40% of FE patients are non-adherent to medication regimes and...
Detailed Description
The primary problem to be addressed is the incomplete functional recovery following a FE of SCZ and whether CBT is an effective treatment to aid this recovery. If CBT were to positively impact recover...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- stabilized outpatients,
- ages 16 to 35
- meet DSM-IV criteria for: schizophrenia, schizophreniform disorder, brief psychotic disorder, delusional disorder, schizoaffective disorder, substance induced psychotic disorder, or psychotic disorder NOS. Participants who also meet DSM-IV criteria for substance abuse or dependence will not be excluded.
- are competent and willing to give consent
- are within 12 months of admission to the FEPP for a FE.
- Exclusion:
- serious risk of suicide or violence to others
- a primary diagnosis of drug-induced psychosis or psychosis due to a general medical condition.
Exclusion
Key Trial Info
Start Date :
September 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2013
Estimated Enrollment :
330 Patients enrolled
Trial Details
Trial ID
NCT00722163
Start Date
September 1 2007
End Date
March 1 2013
Last Update
July 25 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre for Addiction and Mental Health
Toronto, Ontario, Canada, M5T 1R8